Papp, K. A., Merola, J. F., Gottlieb, A. B., Griffiths, C. E., Harris, K. K., Cross, N., Peterson, L., Cioffi, C. and Blauvelt, A. (2019) “Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study”, SKIN The Journal of Cutaneous Medicine, 3, p. S35. doi: 10.25251/skin.3.supp.35.